MRI-derived radiomics model for baseline prediction of prostate cancer progression on active surveillance

Nearly half of patients with prostate cancer (PCa) harbour low- or intermediate-risk disease considered suitable for active surveillance (AS). However, up to 44% of patients discontinue AS within the first five years, highlighting the unmet clinical need for robust baseline risk-stratification tools...

Descripción completa

Detalles Bibliográficos
Autores principales: Sushentsev, Nikita, Rundo, Leonardo, Blyuss, Oleg, Gnanapragasam, Vincent J., Sala, Evis, Barrett, Tristan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217549/
https://www.ncbi.nlm.nih.gov/pubmed/34155265
http://dx.doi.org/10.1038/s41598-021-92341-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217549/
https://www.ncbi.nlm.nih.gov/pubmed/34155265
http://dx.doi.org/10.1038/s41598-021-92341-6

Ejemplares similares